Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $14.01 in the prior trading day, ARS Pharmaceuticals Inc (NASDAQ: SPRY) closed at $13.78, down -1.64%. In other words, the price has decreased by -$1.64 from its previous closing price. On the day, 1.05 million shares were traded. SPRY stock price reached its highest trading level at $14.37 during the session, while it also had its lowest trading level at $13.58.
Ratios:
Our goal is to gain a better understanding of SPRY by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.50 and its Current Ratio is at 12.54. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On August 13, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $18 to $22.
Leerink Partners reiterated its Outperform rating for the stock on August 12, 2024, while the target price for the stock was revised from $19 to $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 15 ’24 when Chakma Justin bought 236,380 shares for $17.30 per share.
Tanimoto Sarina sold 100,000 shares of SPRY for $1,684,642 on Nov 12 ’24. The CHIEF MEDICAL OFFICER now owns 1,248,499 shares after completing the transaction at $16.85 per share. On Nov 12 ’24, another insider, Lowenthal Richard E, who serves as the PRESIDENT AND CEO of the company, sold 100,000 shares for $16.85 each. As a result, the insider received 1,684,642 and left with 1,248,499 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 1339216256 and an Enterprise Value of 1154900992. For the stock, the TTM Price-to-Sale (P/S) ratio is 517.40 while its Price-to-Book (P/B) ratio in mrq is 6.66. Its current Enterprise Value per Revenue stands at 449.728 whereas that against EBITDA is -19.107.
Stock Price History:
Over the past 52 weeks, SPRY has reached a high of $18.51, while it has fallen to a 52-week low of $4.28. The 50-Day Moving Average of the stock is -6.07%, while the 200-Day Moving Average is calculated to be 27.35%.
Shares Statistics:
The stock has traded on average 1.16M shares per day over the past 3-months and 1688720 shares per day over the last 10 days, according to various share statistics. A total of 96.41M shares are outstanding, with a floating share count of 50.64M. Insiders hold about 47.89% of the company’s shares, while institutions hold 42.07% stake in the company. Shares short for SPRY as of 1730332800 were 12597445 with a Short Ratio of 10.82, compared to 1727654400 on 11097485. Therefore, it implies a Short% of Shares Outstanding of 12597445 and a Short% of Float of 24.490000000000002.
